NIDDK Emerging Therapies and Oral GLP-1 Options Eli Lillys development of orforglipron, an oral GLP-1 receptor agonist, marks a significant advancement in diabetes treatment
PMID 30790565
Davis believes that men are often underserved in the weight loss space, which is why Davis Aesthetic Weight Loss takes time to understand the unique goals, challenges, and lifestyles of male patients
PPARgamma coactivator-1alpha expression during thyroid hormone- and contractile activity-induced mitochondrial adaptations
"L-carnitine exerts a nutrigenomic effect via direct modulation of nuclear receptor signaling in adipocytes, hepatocytes and SKMC, demonstrating its nutritional impact." Nutrition Research , January 2021, Jeukendrup, A E et al
Healthcare experts have stressed that behavioral modification is critical for patients to successfully take GLP-1 medications and maintain weight loss